BI-2852
Product Detail
Product Tags
| Pack Size | Availability | Price (USD) |
Chemical Name:
(S)-5-hydroxy-3-(2-((((1-((1-methyl-1H-imidazol-4-yl)methyl)-1H-indol-6-yl)methyl)amino)methyl)-1H-indol-3-yl)isoindolin-1-one
SMILES Code:
OC(C=C1)=CC([C@@H](C2=C(CNCC3=CC4=C(C=CN4CC5=CN(C)C=N5)C=C3)NC6=CC=CC=C62)N7)=C1C7=O
InChi Code:
InChI=1S/C31H28N6O2/c1-36-16-21(33-18-36)17-37-11-10-20-7-6-19(12-28(20)37)14-32-15-27-29(24-4-2-3-5-26(24)34-27)30-25-13-22(38)8-9-23(25)31(39)35-30/h2-13,16,18,30,32,34,38H,14-15,17H2,1H3,(H,35,39)/t30-/m0/s1
InChi Key:
JYEQLXOWWLNVDX-PMERELPUSA-N
Keyword:
Solubility:
Storage:
Description:
BI-2852 is a potent KRAS inhibitor that binds with nanomolar affinity to a pocket, thus far perceived to be "undruggable," between switch I and II on RAS. BI-2852 is mechanistically distinct from covalent KRASG12C inhibitors because it binds to a different pocket present in both the active and inactive forms of KRAS. BI-2852 blocks GEF, GAP, and effector interactions with KRAS, leading to inhibition of downstream signaling and an antiproliferative effect in KRAS mutant cells.
Target: KRAS
![1-Piperidinecarboxylic acid, 3-[4-[(E)-[(dimethylamino)methylene]amino]-2,3-dihydro-2-oxo-1H-imidazo[4,5-c]pyridin-1-yl]-, 1,1-dimethylethyl ester, (3R)](https://www.caerulumpharm.com/uploads/20240604095850.jpg)



![8-bromo-5-chloro-[1,2,4]triazolo[4,3-c]pyrimidine](https://www.caerulumpharm.com/uploads/20241114153539.jpg)
![2-amino-1-butyl-7-methoxy-1H-benzo[d]imidazole-5-carboxamide](https://www.caerulumpharm.com/uploads/微信截图_20230912095525.png)